Posts Tagged ‘big pharma’

Mass. Ban of Pharmaceutical Dinners Ultimately Affects Patients

Tuesday, July 20th, 2010

The other day I had an interesting discussion with my friend Joe, who is the general manager of a local restaurant. During a recent appointment with his primary care physician, his doctor spoke about Massachusetts’ ban of pharmaceutical dinners last year and how it has affected his quality of care.

Marketing codes in MA, which went into effect last July, ban the private functions that restaurants thrived upon and disallow pharmaceutical companies to offer free meals, gifts, entertainment and more to doctors; also, the meetings must be held in an office, hospital or training facility and not off site. These dinners hosted by drug manufacturers provided educational presentations about new treatments, information which is now more difficult to obtain.

In lieu of these dinners, drug representatives travel from hospital to hospital to educate doctors about new treatments. Joe’s doctor raised a great point: Who, especially in a busy office, has time to speak with drug reps in between patients? He certainly doesn’t, and the lack of convenient, informational dinners ultimately affects patients, as the same old treatments are prescribed over and over.

The patient-physician dialogue is becoming more equal as the ePatient movement builds steam. Massachusetts has some of the best hospitals in the world, and the strict marketing codes affecting its health care providers prove how important it really is to join the movement. Become engaged in your health by researching conditions, symptoms and treatments for a more educated, efficient conversation with your physician.

UPDATE: Drug Makers Covered Up Knowledge of Diabetes Treatment Issues

Wednesday, July 14th, 2010

As we previously blogged, studies published two weeks ago reported diabetes drug Avandia had significant cardiovascular side effects, prompting a debate over whether it should be pulled from the market. According to a documents obtained by the New York Times, Avanadia manufacturer GlaxoSmithKline performed a study on the drug in 1999 and the results were the same: the medication increased the risk of heart complications, including heart attack, stroke, heart failure and even death.

Data like this is required to be submitted to federal drug regulators, but the drug maker has spent 11 years covering it up.

The reason for the cover-up was for business only. GlaxoSmithKline would suffer a $600 million loss in two years’ time if the information was released, and they had no other marketable products to offer at that time. The Food and Drug Administration will meet today to discuss the ethics of further testing Avandia against its healthier competitor, Actos, and if it will cease production.

How do you feel about your health industry putting you at risk for a profit? With Healthetreatment, patients experiencing negative side effects can sound off as it happens and search for alternative treatments in our database. Real-time insight from patients, Healthetreatment can become an early-warning system for patients like you.

A Suggestion for the World Health Organization in Tracking the Spread of H1N1

Wednesday, June 9th, 2010

The World Health Organization (WHO) has recently come under fire for allegations that it may have been influenced by the pharmaceutical industry when declaring the H1N1 virus a pandemic. But to most consumers of health care, the scientific basis of the WHO’s declaration of a pandemic is no better understood than the ingredients of a pharmaceutical vaccination.

The WHO is – and should be – in communication with pharmaceutical companies about the spread of contagious diseases. If the two are not in lockstep, the worst possible outcome becomes probable: a worldwide pandemic without enough vaccine to combat and manage the rapid spread of a deadly disease.

Was the WHO influenced by big pharma? That may be a red herring. Shouldn’t the discussion be about the best available data and resources to track the rampant spread of a viral disease? And, is the WHO tracking the spread of disease in a transparent way so that the end consumers of health products  feel safe and well-informed?

We live in the age of Twitter, citizen journalism, and flashmobs where there is no quicker way to capture and publish data than the Internet. There is no traditional method of data collection that provides the immediacy of an online survey. And there is no more capable, more motivated, health consumer than John Q. Public.

Healthetreatment.com is a new kind of health website that collects information directly from consumers. The information is captured and stored anonymously, but statistics are presented in aggregate to visitors of the website so they can be better informed about health issues. Healthetreatment captures demographic info as part of the survey as well, so outcomes can be tracked by gender, age and geographic location.

Want to know the most severe symptoms of Fibromyalgia? Check Healthetreatment. Want to know the most effective medication for sufferers of Crohn’s Disease? It’s there too.

Want to track the spread of H1N1 in real-time? Direct the public to www.healthetreatment.com and offload some of the heavy lifting.